The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJust Eat Takeaw Regulatory News (JET)

Share Price Information for Just Eat Takeaw (JET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,202.00
Bid: 1,190.00
Ask: 1,194.00
Change: -4.00 (-0.33%)
Spread: 4.00 (0.336%)
Open: 1,228.00
High: 1,228.00
Low: 1,186.00
Prev. Close: 1,206.00
JET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

18 Oct 2023 07:00

RNS Number : 5069Q
Just Eat Takeaway.com N.V.
18 October 2023

Amsterdam, 18 October 2023

Just Eat Takeaway.com announces share buyback programme of up to ?150 million

Just Eat Takeaway.com has announced the start of a new share buyback programme to improve future earnings per share under which it plans to repurchase ordinary shares in the amount of up to ?150 million and for a number of shares not exceeding the authority granted by the general meeting (10% of the issued shares). The repurchased shares will be used to cover the Company's obligations under share-based compensation arrangements or will be cancelled to reduce issued share capital.

The buyback programme will commence on 18 October 2023 and is expected to complete no later than 30 September 2024. The number of shares to be repurchased will be within the authorisation (10% of the issued shares) of the general meeting of Just Eat Takeaway.com granted to the Management Board.[1] The maximum number of shares to be repurchased is approximately 5.7% of the Just Eat Takeaway.com issued share capital, based on the closing share price on 17 October 2023 of ?11.92.

The execution of the share buyback programme will be done under the terms of an engagement letter with a third party, performed in compliance with the safe harbour provisions for repurchasing shares under the European Market Abuse Regulation. Shares are bought in the market and accumulated on the treasury share account until settlement under the employee incentive plans or cancellation. As the programme will be lead-managed by the third party within pre-defined execution parameters, transactions may be carried out during closed periods.

The Company will inform the market of the progress made in the execution of this programme through updates on its website (https://www.justeattakeaway.com/investors). In accordance with normal practice to cater for possible changes in future circumstances, the programme does not obligate the Company to acquire any amount of shares, and it may be suspended at any time at the Company's discretion.

Just Eat Takeaway.com

Jitse Groen, CEO

Brent Wissink, CFO

Joerg Gerbig, COO

Andrew Kenny, CCO

Investors:Joris WiltonE: IR@justeattakeaway.com

Media:E: press@justeattakeaway.com

For more information, please visit our corporate website: https://justeattakeaway.com

About Just Eat Takeaway.com

Just Eat Takeaway.com (LSE: JET, AMS: TKWY) is one of the world's leading global online food delivery marketplaces.

Headquartered in Amsterdam, the Company is focused on connecting consumers and partners through its platforms. With 679,000 connected partners, Just Eat Takeaway.com offers consumers a wide variety of food choice.

Just Eat Takeaway.com has rapidly grown to become a leading online food delivery marketplace with operations in Australia, Austria, Belgium, Bulgaria, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Luxembourg, New Zealand, Poland, Slovakia, Spain, Switzerland, the Netherlands, the United Kingdom and the United States.

Most recent information is available on our corporate website and follow us on LinkedIn and X.

Disclaimer

Statements included in this press release that are not historical facts (including any statements concerning investment objectives, other plans and objectives of management for future operations or economic performance, or assumptions or forecasts related thereto) are, or may be deemed to be, forward-looking statements, including "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "anticipates", "expects", "intends", "may", or "will" or, in each case, their negative or other variations or comparable terminology, or, by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. Forward-looking statements reflect knowledge and information available at, and speak only as of, the date they are made, and the Company expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statement contained in this press release. Readers are cautioned not to place undue reliance on such forward-looking statements.


[1] The current authorisation of the general meeting has been obtained on 17 May 2023 and is valid for 18 months, ending on 17 November 2024. Should the general meeting approve a new authorisation of the Management Board to repurchase shares in its meeting to be held in May 2024, the new authorisation will replace the authorisation dated on 17 May 2023.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSNKFBKPBDKNKD
Date   Source Headline
25th Apr 202410:23 amRNSDirector/PDMR Shareholding
22nd Apr 20245:00 pmRNSTransaction in Own Shares
17th Apr 20247:00 amRNSQ1 2024 Trading Update
15th Apr 20245:00 pmRNSTransaction in Own Shares
8th Apr 20245:00 pmRNSTransaction in Own Shares
4th Apr 20243:00 pmRNSNotice of AGM
2nd Apr 20247:07 amRNSTransaction in Own Shares
25th Mar 20245:00 pmRNSTransaction in Own Shares
18th Mar 20245:00 pmRNSTransaction in Own Shares
11th Mar 20245:00 pmRNSTransaction in Own Shares
4th Mar 20245:00 pmRNSTransaction in Own Shares
28th Feb 20247:10 amRNSAnnual Financial Report
26th Feb 20245:00 pmRNSTransaction in Own Shares
19th Feb 20245:00 pmRNSTransaction in Own Shares
7th Feb 20247:01 amRNSDirectorate Change
5th Feb 20245:00 pmRNSTransaction in Own Shares
29th Jan 20245:00 pmRNSTransaction in Own Shares
22nd Jan 20245:00 pmRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTrading Statement
15th Jan 20245:00 pmRNSTransaction in Own Shares
8th Jan 20245:00 pmRNSTransaction in Own Shares
2nd Jan 20247:20 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20232:11 pmRNSBlock listing Interim Review
18th Dec 20235:00 pmRNSTransaction in Own Shares
11th Dec 20235:00 pmRNSTransaction in Own Shares
4th Dec 20235:00 pmRNSTransaction in Own Shares
27th Nov 20235:00 pmRNSTransaction in Own Shares
20th Nov 20235:00 pmRNSTransaction in Own Shares
13th Nov 20235:00 pmRNSTransaction in Own Shares
6th Nov 20235:00 pmRNSTransaction in Own Shares
30th Oct 20235:00 pmRNSTransaction in Own Shares
24th Oct 20234:55 pmRNSDirector/PDMR Shareholding
23rd Oct 20236:00 pmRNSTransaction in Own Shares
18th Oct 20232:47 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSQ3 2023 Trading Update
20th Sep 20235:25 pmRNSTransaction in Own Shares
20th Sep 20235:25 pmRNSTransaction in Own Shares
18th Sep 20235:00 pmRNSTransaction in Own Shares
11th Sep 20235:00 pmRNSTransaction in Own Shares
8th Sep 20239:08 amRNSHolding(s) in Company
7th Sep 20231:18 pmRNSHolding(s) in Company
6th Sep 20237:30 amRNSHolding(s) in Company
4th Sep 20235:00 pmRNSTransaction in Own Shares
4th Sep 20233:09 pmRNSHolding(s) in Company
1st Sep 20234:45 pmRNSHolding(s) in Company
29th Aug 20235:00 pmRNSTransaction in Own Shares
21st Aug 20235:00 pmRNSTransaction in Own Shares
21st Aug 20233:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.